Physician profile
Holly Major
NPI 1215034806
$715.73
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.21 · 2022: $202 · 2023: $413 · 2024: $27.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $322.69 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $187.31 | 2022-2023 | Eliquis, Camzyos |
| Lilly USA, LLC | $86.71 | 2022-2023 | Mounjaro, Trulicity |
| Glaxosmithkline, LLC. | $46.81 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $19.79 | 2021 | |
| Ironwood Pharmaceuticals, INC | $18.81 | 2023 | Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.81 | 2022 | |
| Pfizer INC. | $16.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Major listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.